Skip to main content
. 2018 Aug 24;18(5):4175–4184. doi: 10.3892/mmr.2018.9426

Table III.

Epidermal growth factor receptor-tyrosine kinase inhibitory activity of target molecules.

Compound IC50 (in µM)
1a 112.45±21.52
1b 34.05±4.11
1c 8.45±0.65
1d 2.54±0.22
Dacomitinib 0.06±0.01